Galapagos NV

NASDAQ: GLPG
$25.08
-$0.56 (-2.2%)
Closing Price on November 21, 2024

GLPG Stock Chart and Intraday Price

GLPG Stock Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address GEN DE WITTELAAN L11 A3, 2800 MECHELEN, BE
Fiscal Year End December
Latest Quarter 9/30/2023
Market Cap 2,348.90M USD
Shares Outstanding 65,897,000
Galapagos NV is a pioneering biopharmaceutical company based in Mechelen, Belgium, focusing on the discovery, development, and commercialization of innovative medicines for diseases with significant unmet medical needs. Its notable work includes the development of filgotinib, a promising treatment for various inflammatory conditions, and a portfolio of other potential therapies in different stages of clinical trials. Galapagos NV collaborates with leading global pharmaceutical companies like Gilead Sciences, AbbVie, and Novartis to bring groundbreaking treatments to patients worldwide.

GLPG Articles

Top Analyst Upgrades and Downgrades: Alphabet, Facebook, Harley-Davidson, JetBlue, Lowe's, Occidental, Overstock.com, Snap, Southwest Air and More
Wednesday's top analyst upgrades and downgrades included Alphabet, Facebook, Harley-Davidson, JetBlue Airways, Lowe's Companies, Occidental Petroleum, Overstock.com, Snap and Southwest Airlines.
Lee Jackson
Published:

Top Analyst Upgrades and Downgrades: Advance Auto Parts, Dish Network, Intuit, Kroger, Palo Alto Networks, Starbucks, Texas Instruments and More
Tuesday's top analyst upgrades and downgrades included Advance Auto Parts, Dish Network, Intuit, Kroger, Palo Alto Networks, Qorvo, Starbucks and Texas Instruments.
Lee Jackson
Published:

Why Gilead Retreated on Rheumatoid Arthritis Treatment
Galapagos was crushed on Wednesday after the firm, in conjunction with Gilead, announced a new commercialization and development agreement for their Rheumatoid Arthritis (RA) treatment.
Chris Lange
Published:

Top Analyst Upgrades and Downgrades: Crocs, Gap, GW Pharma, Lowe's, Merck, Nio, Palo Alto, Phillips 66, Starbucks, Vital Farms and More
Tuesday's top analyst upgrades and downgrades included Crocs, Gap, GW Pharmaceuticals, Lowe's Companies, Merck, Nio, Palo Alto Networks, Phillips 66, Starbucks and Vital Farms.
Jon C. Ogg
Published:

The FDA Comes Down on Gilead and Galapagos With CRL
The FDA has come down on an investigational treatment for moderately to severely active from Gilead Sciences and Galapagos.
Chris Lange
Published:

Top Analyst Upgrades and Downgrades: Agilent, Antero, Chewy, Domino's, eHealth, First Solar, Kraft Heinz, Newmont, Square, Tilray, Wayfair and More
Monday's top analyst upgrades, downgrades and initiations included Agilent Technologies, Antero Midstream, Chewy, Domino's Pizza, eHealth, First Solar, Kraft Heinz, Newmont, Square, Tilray and...
Jon C. Ogg
Published:
Last Updated:

Top Analyst Upgrades and Downgrades: AMD, AEP, Analog Devices, CenturyLink, Dish, Herbalife, NextEra, NRG, On Semi, SolarEdge and More
Thursday's top analyst upgrades, downgrades and initiations included Advanced Micro Devices, American Electric Power, Analog Devices, CenturyLink, Dish Network, Herbalife, NextEra Energy, NRG Energy,...
Jon C. Ogg
Published:

Top Analyst Upgrades and Downgrades: Alphabet, Apple, BofA, Citigroup, Dollar Tree, Nordstrom, Salesforce, Travelers, JD.com and More
Monday's top analyst upgrades, downgrades and initiations included Alphabet, Apple, Bank of America, Citigroup, Dollar Tree, Nordstrom, Salesforce, Travelers and JD.com.
Jon C. Ogg
Published: